New: NCI-funded clinical trial search
Mednet Logo

How do you optimize a beta thalassemia patient on luspatercept who is interested in becoming pregnant?

When do you stop luspatercept? How do you approach iron chelation therapy if the patient is currently on therapy?
1 Answer
Mednet MemberInvited Expert
Pediatric Hematology/Oncology · Weill Cornell Medical College
Answered on

Unfortunately, luspatercept is not approved to be used during pregnancy - there is no data available on the safety of the drug during pregnancy. So would say that if the patient is planning a pregnancy, would stop luspatercept at least 3 months prior.

It is strongly recommended to optimize iron balance prior to pregnancy and get the liver iron down as low as possible in the 2-5 mg/g range. This way, the increase in iron levels through the pregnancy will not raise the iron too much and also optimize cardiac iron management.

If on chelation, would suggest stopping it as soon as the patient learns she is pregnant. Would not recommend stopping it in the planning stages. Chelation is usually held through the entire pregnancy, unless the patient ...

Join for free or sign in to see the full answer